Biocon redeems commercial papers of Rs 2,250 crore

23 Feb 2023 Evaluate

Biocon has fulfilled its payment obligation and has fully redeemed the Commercial Papers (CPs) of Rs 2,250 crore. The maturity date of the said commercial papers was February 22, 2023 and the payment made on the same date.

Earlier, the company had raised Rs 1070 crore through allotment of 1,07,000 unlisted, secured, rated, redeemable, non-convertible debentures (NCDs) of face value of Rs 1,00,000 each on private placement basis in 3 series.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

316.15 -4.65 (-1.45%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.